TIMP2 gene polymorphisms are associated with hypertension in patients with myocardial infarction

[1]  Dong Hwan Kim,et al.  Association between IL10, IL10RA, and IL10RB SNPs and ischemic stroke with hypertension in Korean population , 2013, Molecular Biology Reports.

[2]  R. Vasan,et al.  Biomarkers of Extracellular Matrix Metabolism (MMP-9 and TIMP-1) and Risk of Stroke, Myocardial Infarction, and Cause-Specific Mortality: Cohort Study , 2011, PloS one.

[3]  Qi Zhang,et al.  Polymorphisms of MMP-3 and TIMP-4 genes affect angiographic coronary plaque progression in non-diabetic and type 2 diabetic patients. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[4]  S. K. Kim,et al.  Promoter Polymorphism (rs3755724, -55C/T) of Tissue Inhibitor of Metalloproteinase 4 (TIMP4) as a Risk Factor for Kawasaki Disease with Coronary Artery Lesions in a Korean Population , 2009, Pediatric Cardiology.

[5]  Satwat Hashmi,et al.  Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome. , 2008, The Canadian journal of cardiology.

[6]  H. Markus,et al.  Polymorphisms in MMP Family and TIMP Genes and Carotid Artery Intima-Media Thickness , 2007, Stroke.

[7]  B. Horne,et al.  Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease. , 2007, American heart journal.

[8]  Toshiro Hara,et al.  Tissue inhibitor of metalloproteinase 2 and coronary artery lesions in Kawasaki disease. , 2007, The Journal of pediatrics.

[9]  Aiqing He,et al.  The Unfolded Protein Response Is an Important Regulator of Inflammatory Genes in Endothelial Cells , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[10]  Chia-Hung Liu,et al.  FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization , 2006, Nucleic Acids Res..

[11]  Leslie L. Clark,et al.  Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases: Relationship Between Changes in Proteolytic Determinants of Matrix Composition and Structural, Functional, and Clinical Manifestations of Hypertensive Heart Disease , 2006, Circulation.

[12]  A. Sterpetti,et al.  Metalloproteinases and their inhibitors are markers of plaque instability. , 2005, Surgery.

[13]  David Handelsman,et al.  Androgens and cardiovascular disease. , 2003, Endocrine reviews.

[14]  H. Mabuchi,et al.  Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary Atherosclerosis , 2001, Clinical chemistry and laboratory medicine.

[15]  J. Ye,et al.  Cloning of the human tissue inhibitor of metalloproteinase-4 gene (TIMP4) and localization of the TIMP4 and Timp4 genes to human chromosome 3p25 and mouse chromosome 6, respectively. , 1998, Genomics.

[16]  A. Bowcock,et al.  Structure and Characterization of the Human Tissue Inhibitor of Metalloproteinases-2 Gene* , 1996, The Journal of Biological Chemistry.

[17]  H. Stöhr,et al.  Genomic organization of the human tissue inhibitor of metalloproteinases-3 (TIMP3) , 1995, Genome research.

[18]  J. McEwan,et al.  Matrix metalloproteinases and cardiovascular disease. , 1995, Circulation research.

[19]  P. Libby,et al.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.

[20]  J. Nurnberger,et al.  A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. , 1991, Nucleic acids research.

[21]  R. Tjian,et al.  Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro , 1988, Nature.

[22]  R. Punnett,et al.  The journal of genetics , 1910, Zeitschrift für Induktive Abstammungs- und Vererbungslehre.

[23]  Stefan Agewall,et al.  Matrix metalloproteinases and cardiovascular disease. , 2006, European heart journal.

[24]  A. Newby,et al.  Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. , 2005, Physiological reviews.

[25]  F Matzkies,et al.  Tubular gelatinase A (MMP-2) and its tissue inhibitors in polycystic kidney disease in the Han:SPRD rat. , 1996, Kidney international.